secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medtronic plc (MDT)
CIK:        0001613103
Form:       8-K
Filed at:   2023-08-22T23:59:59+00:00
Accession:  0001613103-23-000117
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medtronic Q1 revenue $7.7B (+6% organic); raises FY24 guidance
--------------------------------------------------------------

- Revenue $7.70B, +4.5% reported, +6.0% organic; GAAP EPS $0.59 (-16%), non-GAAP EPS $1.20 (+6%).
- FY24 organic revenue growth guidance raised to 4.5% (from 4.0-4.5%); non-GAAP EPS guidance raised to $5.08-$5.16 (from $5.00-$5.10).
- All four segments delivered 6% organic growth: Cardiovascular +6.2%, Neuroscience +5.6%, Medical Surgical +6.1%, Diabetes +6.3%.
- U.S. launches commenced for MiniMed 780G system and Micra AV2/VR2 leadless pacemakers.
- Management cites broad strength and improved fundamentals; raises guidance based on Q1 outperformance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613103/000161310323000117/0001613103-23-000117-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613103/000161310323000117/mdt-20230822.htm
  HTML page:      https://secwatch.observer/filing/0001613103-23-000117

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer